← Leaderboards
Shohei Koide
New York University
$16,409,478
Attributed
$21,991,067
Total exposure
19
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,991,067 · 19
By mechanism
R01$17,528,390 · 8
R21$2,105,705 · 5
RC1$1,000,000 · 1
R41$608,701 · 1
U54$509,698 · 1
R29$222,600 · 1
Top collaborators
- John P O'Bryan11 shared
- Nathaniel J. Traaseth6 shared
- Da-Neng Wang6 shared
- Dafna Bar-Sagi3 shared
- Craig Patrick Ramirez2 shared
- Thales Papagiannakopoulos1 shared
Most similar at New York University
Same institution · by research overlap
- Nathaniel J. Traaseth$7,360,173
- Da-Neng Wang$18,349,403
- Eric C Chang$3,896,660
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsCellsAntibodiesProtein EngineeringSpecificityTechnologyMolecularInnovationAffinityBinding ProteinsReagentBindingPharmaceutical PreparationsCommunitiesBaseNovel StrategiesBiochemicalMutationPerformanceDesignPlayIn VitroSiteComplex
Grant awards (60)
Transport Mechanisms and Inhibition of Efflux Pumps in Pathogenic Organisms$743,532
R01 · FY2025 · AI
Targeting LCN2, a novel therapy for lung cancer$696,569
R01 · FY2025 · CA
Probing RAS-mediated Signaling with Monobody Inhibitors$588,746
R01 · FY2025 · CA
Novel biologic therapeutics targeting vacuolar ATPase localized on plasma membrane$237,724
R21 · FY2025 · CA · contact PI
Transport Mechanisms and Inhibition of Efflux Pumps in Pathogenic Organisms$88,074
R01 · FY2025 · AI
Transport Mechanisms and Inhibition of Efflux Pumps in Pathogenic Organisms$743,532
R01 · FY2024 · AI
Probing RAS-mediated Signaling with Monobody Inhibitors$559,309
R01 · FY2024 · CA
Transport Mechanisms and Inhibition of Efflux Pumps in Pathogenic Organisms$73,396
R01 · FY2024 · AI
Transport Mechanisms and Inhibition of Efflux Pumps in Pathogenic Organisms$743,532
R01 · FY2023 · AI
Probing RAS-mediated Signaling with Monobody Inhibitors$576,970
R01 · FY2023 · CA
Novel biologics platform for targeting tumors driven by intracellular oncoproteins$232,969
R21 · FY2023 · CA · contact PI
Transport Mechanisms and Inhibition of Efflux Pumps in Pathogenic Organisms$743,532
R01 · FY2022 · AI
Probing RAS-mediated Signaling with Monobody Inhibitors$601,496
R01 · FY2022 · CA
A novel monobody-drug conjugate to treat mutant KRas pancreatic cancer.$209,986
R41 · FY2022 · CA
Novel biologics platform for targeting tumors driven by intracellular oncoproteins$198,103
R21 · FY2022 · CA · contact PI
Probing RAS-mediated signaling mechanisms with monobody inhibitors$551,022
R01 · FY2021 · CA
A novel monobody-drug conjugate to treat mutant KRas pancreatic cancer.$398,715
R41 · FY2021 · CA
Probing RAS-mediated signaling mechanisms with monobody inhibitors$551,022
R01 · FY2020 · CA
Accurate prediction of neutralization capacity from deep mining of SARS-CoV-2 serology$466,125
R21 · FY2020 · AI · contact PI
Molecular mechanisms of SHP2 signaling dissected with designer binding proteins$373,531
R01 · FY2020 · CA · contact PI
Probing Ras-mediated signaling mechanisms with monobody inhibitors$152,515
R01 · FY2020 · CA
Probing RAS-mediated signaling mechanisms with monobody inhibitors$534,490
R01 · FY2019 · CA
Molecular mechanisms of SHP2 signaling dissected with designer binding proteins$359,226
R01 · FY2019 · CA · contact PI
Probing RAS-mediated signaling mechanisms with monobody inhibitors$543,570
R01 · FY2018 · CA
Molecular mechanisms of SHP2 signaling dissected with designer binding proteins$367,232
R01 · FY2018 · CA · contact PI
Genetically encoded designer inhibitors for functional epigenomics$410,390
R01 · FY2017 · DA · contact PI
Probing RAS-mediated signaling mechanisms with monobody inhibitors$397,436
R01 · FY2017 · CA
Molecular mechanisms of SHP2 signaling dissected with designer binding proteins$364,217
R01 · FY2017 · CA · contact PI
Probing RAS-mediated signaling mechanisms with monobody inhibitors$179,910
R01 · FY2017 · CA
Genetically encoded designer inhibitors for functional epigenomics$427,765
R01 · FY2016 · DA · contact PI
Molecular mechanisms of SHP2 signaling dissected with designer binding proteins$368,721
R01 · FY2016 · CA · contact PI
Genetically encoded designer inhibitors for functional epigenomics$390,136
R01 · FY2015 · DA · contact PI
Genetically encoded designer inhibitors for functional epigenomics$398,236
R01 · FY2014 · DA · contact PI
Rational generation of directed protein-capture reagents$494,781
R01 · FY2013 · GM · contact PI
Genetically encoded designer inhibitors for functional epigenomics$412,892
R01 · FY2013 · DA · contact PI
Rational generation of directed protein-capture reagents$509,962
R01 · FY2012 · GM · contact PI
Rational generation of directed protein-capture reagents$511,172
R01 · FY2011 · GM · contact PI
SYNTHETIC BINDING PROTEINS$10,975
P41 · FY2011 · RR · contact PI
Core D3: Synthetic Antigen Binder Generation & Crystallography$509,698
U54 · FY2010 · GM · contact PI
Rational generation of directed protein-capture reagents$502,981
R01 · FY2010 · GM · contact PI
Renewable synthetic antibodies for epigenomics$500,000
RC1 · FY2010 · DA · contact PI
Rational generation of directed protein-capture reagents$580,790
R01 · FY2009 · GM · contact PI
Renewable synthetic antibodies for epigenomics$500,000
RC1 · FY2009 · DA · contact PI
Novel affinity reagents for epigenetics markers$301,864
R21 · FY2009 · DA · contact PI
High-performance affinity reagents for peptide epitopes$198,991
R21 · FY2009 · CA · contact PI
Novel affinity reagents for epigenetics markers$301,864
R21 · FY2008 · DA · contact PI
High-performance affinity reagents for peptide epitopes$168,065
R21 · FY2008 · CA · contact PI
INTERACTION MEDIATOR IDENTIFICATION$4,998
P41 · FY2006 · RR · contact PI
Nuclear receptor probed with designer binding proteins$206,830
R01 · FY2005 · DK
STRUCTURE AND STABILITY OF SINGLE-LAYER BETA-SHEETS$87,033
R01 · FY2005 · GM
Nuclear receptor probed with designer binding proteins$206,830
R01 · FY2004 · DK
STRUCTURE AND STABILITY OF SINGLE-LAYER BETA-SHEETS$258,878
R01 · FY2003 · GM
Nuclear receptor probed with designer binding proteins$206,830
R01 · FY2003 · DK
Nuclear receptor probed with designer binding proteins$246,160
R01 · FY2002 · DK
STRUCTURE AND STABILITY OF SINGLE-LAYER BETA-SHEETS$133,426
R01 · FY2002 · GM
STRUCTURE AND STABILITY OF SINGLE-LAYER BETA-SHEETS$126,449
R01 · FY2002 · GM
STRUCTURE AND STABILITY OF SINGLE-LAYER BETA-SHEETS$257,594
R01 · FY2001 · GM
ARTIFICIAL MINIANTIBODIES--FROM DESIGN TO STRUCTURE$111,300
R29 · FY2001 · GM
STRUCTURE AND STABILITY OF SINGLE-LAYER BETA-SHEETS$257,675
R01 · FY2000 · GM
ARTIFICIAL MINIANTIBODIES--FROM DESIGN TO STRUCTURE$111,300
R29 · FY2000 · GM